AU7472798A - Cox-2 inhibitors in combination with nmda-blockers for treating pain - Google Patents

Cox-2 inhibitors in combination with nmda-blockers for treating pain

Info

Publication number
AU7472798A
AU7472798A AU74727/98A AU7472798A AU7472798A AU 7472798 A AU7472798 A AU 7472798A AU 74727/98 A AU74727/98 A AU 74727/98A AU 7472798 A AU7472798 A AU 7472798A AU 7472798 A AU7472798 A AU 7472798A
Authority
AU
Australia
Prior art keywords
nmda
blockers
cox
inhibitors
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU74727/98A
Other languages
English (en)
Inventor
Frank S Caruso
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Endo Pharmaceuticals Inc
Original Assignee
Algos Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Algos Pharmaceutical Corp filed Critical Algos Pharmaceutical Corp
Publication of AU7472798A publication Critical patent/AU7472798A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU74727/98A 1997-05-07 1998-05-06 Cox-2 inhibitors in combination with nmda-blockers for treating pain Abandoned AU7472798A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4591497P 1997-05-07 1997-05-07
US60045914 1997-05-07
PCT/US1998/009252 WO1998050075A1 (fr) 1997-05-07 1998-05-06 Inhibiteurs de cox-2 en combinaison avec des agents bloquants le nmda pour traiter la douleur

Publications (1)

Publication Number Publication Date
AU7472798A true AU7472798A (en) 1998-11-27

Family

ID=21940523

Family Applications (1)

Application Number Title Priority Date Filing Date
AU74727/98A Abandoned AU7472798A (en) 1997-05-07 1998-05-06 Cox-2 inhibitors in combination with nmda-blockers for treating pain

Country Status (2)

Country Link
AU (1) AU7472798A (fr)
WO (1) WO1998050075A1 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294558B1 (en) 1999-05-31 2001-09-25 Pfizer Inc. Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
US6727238B2 (en) 1998-06-11 2004-04-27 Pfizer Inc. Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
AU1408699A (en) * 1998-11-12 2000-06-05 Algos Pharmaceutical Corporation Cox-2 inhibitors in combination with nmda-blockers for treating pain
AU1398899A (en) * 1998-11-12 2000-06-05 Algos Pharmaceutical Corporation Cox-2 inhibitors in combination with centrally acting analgesics
NZ513924A (en) * 1999-03-01 2001-09-28 Ortho Mcneil Pharm Inc Composition comprising a tramadol material and a selective cox-2 inhibitor drug
DE10059020A1 (de) * 2000-11-28 2002-05-29 Gruenenthal Gmbh Parenteral applizierbare Darreichungsformen
EP1395289B1 (fr) 2001-06-07 2010-12-15 Christine Dr. Sang Traitement de la douleur nevropathique avec des antagonistes du recepteur n-methyl-d-aspartate (nmda)
US20040082543A1 (en) * 2002-10-29 2004-04-29 Pharmacia Corporation Compositions of cyclooxygenase-2 selective inhibitors and NMDA receptor antagonists for the treatment or prevention of neuropathic pain
US7732162B2 (en) 2003-05-05 2010-06-08 Probiodrug Ag Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
CA2519189C (fr) 2003-05-07 2012-07-17 Osteologix A/S Sels de strontium solubles dans l'eau pour le traitement de maladies des cartilages et/ou des os
WO2008055945A1 (fr) 2006-11-09 2008-05-15 Probiodrug Ag Dérivés 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one utiles en tant qu' inhibiteurs de la glutaminyl-cyclase dans le traitement des ulcères, du cancer et d'autres maladies
ATE554085T1 (de) 2006-11-30 2012-05-15 Probiodrug Ag Neue inhibitoren von glutaminylcyclase
EP2117540A1 (fr) 2007-03-01 2009-11-18 Probiodrug AG Nouvelle utilisation d'inhibiteurs de la glutaminyl cyclase
JP5667440B2 (ja) 2007-04-18 2015-02-12 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤としてのチオ尿素誘導体
SG178953A1 (en) 2009-09-11 2012-04-27 Probiodrug Ag Heterocylcic derivatives as inhibitors of glutaminyl cyclase
US9181233B2 (en) 2010-03-03 2015-11-10 Probiodrug Ag Inhibitors of glutaminyl cyclase
AU2011226074B2 (en) 2010-03-10 2015-01-22 Vivoryon Therapeutics N.V. Heterocyclic inhibitors of glutaminyl cyclase (QC, EC 2.3.2.5)
US8541596B2 (en) 2010-04-21 2013-09-24 Probiodrug Ag Inhibitors
ES2570167T3 (es) 2011-03-16 2016-05-17 Probiodrug Ag Derivados de benzimidazol como inhibidores de glutaminil ciclasa
US10195153B2 (en) 2013-08-12 2019-02-05 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US10172797B2 (en) 2013-12-17 2019-01-08 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
JP6371463B2 (ja) 2014-07-17 2018-08-08 ファーマシューティカル マニュファクチュアリング リサーチ サービシズ，インコーポレーテッド 即時放出性乱用抑止性液体充填剤形
ES2812698T3 (es) 2017-09-29 2021-03-18 Probiodrug Ag Inhibidores de glutaminil ciclasa

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5409944A (en) * 1993-03-12 1995-04-25 Merck Frosst Canada, Inc. Alkanesulfonamido-1-indanone derivatives as inhibitors of cyclooxygenase
US5521213A (en) * 1994-08-29 1996-05-28 Merck Frosst Canada, Inc. Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2
EP0778770B1 (fr) * 1994-09-02 2003-12-10 Virginia Commonwealth University Composition soulageant la douleur contenant un analgesique non narcotique et un activateur d'analgesie

Also Published As

Publication number Publication date
WO1998050075A1 (fr) 1998-11-12

Similar Documents

Publication Publication Date Title
AU7472798A (en) Cox-2 inhibitors in combination with nmda-blockers for treating pain
AU7696098A (en) Substance p inhibitors in combination with nmda-blockers for treating pain
AU9035498A (en) Method for treating pain
HUP0004170A3 (en) Methods and materials for treating and preventing inflammation ofmucosal tissue
AU6131199A (en) Insertion device for stents and methods for use
AU1912695A (en) Dna damaging agents in combination with tyrosine kinase inhibitors
AU5382099A (en) Apparatus and methods for radiotherapy
PL331346A1 (en) Hppd gene and inhibitors
AU7383398A (en) Therapeutic glasses and method for using the same
AU8693098A (en) Compositions and methods for treating diabetes
AU3195200A (en) Liquid treating method and liquid treating system
AU9174798A (en) Magnetotherapy device
AU6136499A (en) Injector, methods for using injector, and kit
AU6059198A (en) Borate cross-linked well treating fluids and methods
AU6157899A (en) Catheter flush solution and method for its use
HUP0103473A3 (en) Phosphoglycolipid and methods for its use
AU7027098A (en) Method and device for surface treatment
AU5056099A (en) Compounds for use in the treatment of inflammation
AU1398899A (en) Cox-2 inhibitors in combination with centrally acting analgesics
AU2020097A (en) Cold therapy device
AU9034798A (en) Method for treating pain
AU2529799A (en) Benzofuran-4-carboxamides and their therapeutic use
AU4877897A (en) Inhibitors and their uses in oils
AU6966998A (en) Composition for treating pain
AU5167099A (en) Process and device for treating surfaces

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase